Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern cooperative oncology group study E3501

Leora Horn, Suzanne E. Dahlberg, Alan B. Sandler, Afshin Dowlati, Dennis F. Moore, John R. Murren, Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern cooperative oncology group study E3501'. Together they form a unique fingerprint.

Medicine & Life Sciences